---
input_text: |
  Naturally occurring canine cancers have remarkable similarities to their human counterparts. To better understand these similarities, we investigated 671 client-owned dogs from 96 breeds with 23 common tumor types, including those whose mutation profile are unknown (anal sac carcinoma and neuroendocrine carcinoma) or understudied (thyroid carcinoma, soft tissue sarcoma and hepatocellular carcinoma). We discovered mutations in 50 well-established oncogenes and tumor suppressors, and compared them to those reported in human cancers. As in human cancer, TP53 is the most commonly mutated gene, detected in 22.5% of canine tumors overall. Canine tumors share mutational hotspots with human tumors in oncogenes including PIK3CA, KRAS, NRAS, BRAF, KIT and EGFR. Hotspot mutations with significant association to tumor type include NRAS G61R and PIK3CA H1047R in hemangiosarcoma, ERBB2 V659E in pulmonary carcinoma, and BRAF V588E (equivalent of V600E in humans) in urothelial carcinoma. Our findings better position canines as a translational model of human cancer to investigate a wide spectrum of targeted therapies. Dogs with the most common splenic form of hemangiosarcoma will usually arrive at an emergency clinic having suddenly collapsed and with pale gums due to internal bleeding from a previously undetected and now ruptured tumor. Internal bleeding sometimes results in sudden death.
raw_completion_output: |-
  cancer: anal sac carcinoma; neuroendocrine carcinoma; thyroid carcinoma; soft tissue sarcoma; hepatocellular carcinoma; hemangiosarcoma; pulmonary carcinoma; urothelial carcinoma; splenic form of hemangiosarcoma
  gene: TP53; PIK3CA; KRAS; NRAS; BRAF; KIT; EGFR; ERBB2
  anatomical_entity: anal sac; neuroendocrine system; thyroid; soft tissue; liver; spleen; lungs; urinary tract
  cancergenelocation: TP53 - overall tumors; NRAS G61R - hemangiosarcoma; PIK3CA H1047R - hemangiosarcoma; ERBB2 V659E - pulmonary carcinoma; BRAF V588E - urothelial carcinoma
  phenotype: suddenly collapsed; pale gums; internal bleeding; sudden death
  cancerphenotype: hemangiosarcoma - suddenly collapsed, pale gums, internal bleeding, sudden death
  bio_process: mutation; targeted therapies; internal bleeding; ruptured tumor
  cancerbio: hemangiosarcoma - mutation, internal bleeding, targeted therapies
prompt: |+
  From the text below, extract the following entities in the following format:

  cancer: <the value for cancer>
  bioprocess: <if multiple cancers are mentioned in text specify one related to the observed change in biological process or chemical entity>


  Text:
  hemangiosarcoma - mutation, internal bleeding, targeted therapies

  ===

extracted_object:
  cancer:
    - AUTO:anal%20sac%20carcinoma
    - MONDO:0002120
    - MESH:M0333546
    - MONDO:0018078
    - MESH:D006528
    - MESH:D006394
    - AUTO:pulmonary%20carcinoma
    - MONDO:0040679
    - AUTO:splenic%20form%20of%20hemangiosarcoma
  gene:
    - HGNC:11998
    - HGNC:8975
    - PR:Q9VNE2
    - HGNC:7989
    - HGNC:1097
    - HGNC:6342
    - HGNC:3236
    - HGNC:3430
  anatomical_entity:
    - UBERON:0008978
    - UBERON:8600018
    - UBERON:0002046
    - AUTO:soft%20tissue
    - UBERON:0002107
    - UBERON:0002106
    - UBERON:0002048
    - UBERON:0001008
  cancergenelocation:
    - cancer: AUTO:overall%20tumors
      gene: HGNC:11998
      location: AUTO:not%20specified
    - cancer: MESH:D006394
      gene: HGNC:7989
      location: AUTO:G61R
    - cancer: MESH:D006394
      gene: HGNC:8975
      location: AUTO:H1047R
    - cancer: AUTO:pulmonary%20carcinoma
      gene: HGNC:3430
      location: AUTO:V659E
    - cancer: MONDO:0040679
      gene: AUTO:BRAF%20V588E
      location: AUTO:N/A
  phenotype:
    - AUTO:suddenly%20collapsed
    - AUTO:pale%20gums
    - HP:0011029
    - HP:0001699
  cancerphenotype:
    - cancer: MESH:D006394
      phenotype: 
        AUTO:sudden%20collapse%2C%20pale%20gums%2C%20internal%20bleeding%2C%20sudden%20death
  bio_process: 
    AUTO:mutation%3B%20targeted%20therapies%3B%20internal%20bleeding%3B%20ruptured%20tumor
  cancerbio:
    - cancer: MESH:D006394
      bioprocess: HP:0011029
named_entities:
  - id: AUTO:anal%20sac%20carcinoma
    label: anal sac carcinoma
  - id: MONDO:0002120
    label: neuroendocrine carcinoma
  - id: MESH:M0333546
    label: thyroid carcinoma
  - id: MONDO:0018078
    label: soft tissue sarcoma
  - id: MESH:D006528
    label: hepatocellular carcinoma
  - id: MESH:D006394
    label: hemangiosarcoma
  - id: AUTO:pulmonary%20carcinoma
    label: pulmonary carcinoma
  - id: MONDO:0040679
    label: urothelial carcinoma
  - id: AUTO:splenic%20form%20of%20hemangiosarcoma
    label: splenic form of hemangiosarcoma
  - id: HGNC:11998
    label: TP53
  - id: HGNC:8975
    label: PIK3CA
  - id: PR:Q9VNE2
    label: KRAS
  - id: HGNC:7989
    label: NRAS
  - id: HGNC:1097
    label: BRAF
  - id: HGNC:6342
    label: KIT
  - id: HGNC:3236
    label: EGFR
  - id: HGNC:3430
    label: ERBB2
  - id: UBERON:0008978
    label: anal sac
  - id: UBERON:8600018
    label: neuroendocrine system
  - id: UBERON:0002046
    label: thyroid
  - id: AUTO:soft%20tissue
    label: soft tissue
  - id: UBERON:0002107
    label: liver
  - id: UBERON:0002106
    label: spleen
  - id: UBERON:0002048
    label: lungs
  - id: UBERON:0001008
    label: urinary tract
  - id: AUTO:overall%20tumors
    label: overall tumors
  - id: AUTO:not%20specified
    label: not specified
  - id: AUTO:G61R
    label: G61R
  - id: AUTO:H1047R
    label: H1047R
  - id: AUTO:V659E
    label: V659E
  - id: AUTO:BRAF%20V588E
    label: BRAF V588E
  - id: AUTO:N/A
    label: N/A
  - id: AUTO:suddenly%20collapsed
    label: suddenly collapsed
  - id: AUTO:pale%20gums
    label: pale gums
  - id: HP:0011029
    label: internal bleeding
  - id: HP:0001699
    label: sudden death
  - id: 
      AUTO:sudden%20collapse%2C%20pale%20gums%2C%20internal%20bleeding%2C%20sudden%20death
    label: sudden collapse, pale gums, internal bleeding, sudden death
  - id: 
      AUTO:mutation%3B%20targeted%20therapies%3B%20internal%20bleeding%3B%20ruptured%20tumor
    label: mutation; targeted therapies; internal bleeding; ruptured tumor
